Saber A Amin (Saber Amin)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Brain Metastases

Prognostic Factors

Top Venues

Future oncology (London, England)

Journal of immunotherapy (Hagerstown, Md. : 1997)

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Saber A Amin, Michael Baine, Chi Lin
Immunotherapy plus stereotactic body radiation therapy or whole-brain radiation therapy in brain metastases. Immunotherapy 15 (3) (2023)
Saber A Amin, Michael Baine, Chi Lin
Immunotherapy plus stereotactic body radiation therapy or whole-brain radiation therapy in brain metastases. Immunotherapy 15 (3) (2023)
Saber A Amin, Michael Baine, Chi Lin
Immunotherapy plus stereotactic body radiation therapy or whole-brain radiation therapy in brain metastases. Immunotherapy 15 (3) (2023)
Saber A Amin, Michael Baine, Chi Lin
Immunotherapy plus stereotactic body radiation therapy or whole-brain radiation therapy in brain metastases. Immunotherapy (2023)
Saber A Amin, Lindsay J Collin, Soko Setoguchi, Jaya M Satagopan, Alexandre Buckley de Meritens, Elisa V Bandera
Neoadjuvant chemotherapy in ovarian cancer: Are there racial disparities in use and survival? Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2022)
Saber A Amin, Michael J Baine, Ibur Rahman, Chi Lin
The Association of Immunotherapy With the Overall Survival of Inoperable Stage III Non-small Cell Lung Cancer Patients Who Do Not Receive Chemoradiation. Journal of immunotherapy (Hagerstown, Md. : 1997) 46 (1) (2022)
Josiah McAllister, Saber A Amin, Chi Lin
Association of facility type with overall survival in patients with nonsurgically managed pancreatic cancer. Future oncology (London, England) 18 (10) (2022)